Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
Certara has entered a strategic partnership with Altasciences to integrate its model-informed drug development services into Altasciences' Acceleration Platform. The collaboration aims to enable sponsors to establish proof of mechanism earlier and design more efficient studies by embedding modeling insights directly into the execution of development programs.
Key figures
- Client count
- more than 2,600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.